These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26215609)

  • 1. Re: Johan Lindberg, Anna Kristiansen, Peter Wiklund, Henrik Grönberg, Lars Egevad. Tracking the Origin of Metastatic Prostate Cancer. Eur Urol 2015;67:819-22.
    Piva F; Santoni M; Scarpelli M; Briganti A; Montorsi F; Montironi R
    Eur Urol; 2015 Dec; 68(6):e134-5. PubMed ID: 26215609
    [No Abstract]   [Full Text] [Related]  

  • 2. Tracking the origin of metastatic prostate cancer.
    Lindberg J; Kristiansen A; Wiklund P; Grönberg H; Egevad L
    Eur Urol; 2015 May; 67(5):819-22. PubMed ID: 25246081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genomic diversity of prostate cancer: our Achilles heel explored.
    Bryant RJ; Verrill C; Hamdy FC
    Eur Urol; 2015 May; 67(5):823-4. PubMed ID: 25433913
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Cathrine Alvær Vinje, Maria Nyre Vigmostad, Svein R. Kjosavik, Henrik Grönberg, Bjørnar Gilje, Svein Skeie. Prostate Biopsies Can Be Omitted in Most Patients with a Positive Stockholm3 Test and Negative Prostate Magnetic Resonance Imaging. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.08.009.
    Liu W; He Y; Yang B
    Eur Urol Focus; 2024 Mar; 10(2):244-245. PubMed ID: 38290858
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Ola Bratt and Anna Öfverholm's Letter to the Editor re: Peter Ström, Tobias Nordström, Henrik Grönberg, Martin Eklund. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.12.028.
    Eklund M; Ström P; Nordström T; Grönberg H
    Eur Urol; 2018 Jul; 74(1):e10-e11. PubMed ID: 29598984
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Peter Ström, Tobias Nordström, Henrik Grönberg, Martin Eklund. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.12.028.
    Bratt O; Öfverholm A
    Eur Urol; 2018 Jul; 74(1):e9. PubMed ID: 29598982
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Erik Rud, Peter Lauritzen, and Eduard Baco's Letter to the Editor re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722-8.
    Eklund M; Ström P; Grönberg H; Nordström T
    Eur Urol; 2019 Apr; 75(4):e104-e105. PubMed ID: 30514569
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139-46.
    Vickers A; Nordström T; Assel M; Lilja H; Grönberg H; Eklund M
    Eur Urol; 2018 Aug; 74(2):e35-e36. PubMed ID: 29731258
    [No Abstract]   [Full Text] [Related]  

  • 9. Fine needle aspiration cytology of a metastatic duct carcinoma of the prostate: a case report.
    Alrahwan D; Staerkel G; Gong Y
    Acta Cytol; 2006; 50(4):469-72. PubMed ID: 16901017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722-8.
    Rud E; Lauritzen P; Baco E
    Eur Urol; 2019 Apr; 75(4):e103. PubMed ID: 30528223
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Peter Ka-Fung Chiu, Xiaobo Wu, Giorgio Gandaglia, European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Beyond Statistical Significance: Unveiling the Advantages of Transperineal Versus Transrectal Prostate Biopsies. Eur Urol. In press.
    Hu JC; Vickers AJ; Schaeffer EM
    Eur Urol; 2024 Jul; 86(1):e18. PubMed ID: 38677934
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Lars Egevad, Hemamali Samaratunga, John R. Srigley, Brett Delahunt's Letter to the Editor re: Anthony Zietman, Joseph Smith, Eric Klein, Michael Droller, Prokar Dasgupta, James Catto. Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required. Eur Urol 2016;70:1.
    Zietman A; Smith J; Klein E; Droller M; Dasgupta P; Catto J
    Eur Urol; 2017 Feb; 71(2):e54. PubMed ID: 27452952
    [No Abstract]   [Full Text] [Related]  

  • 13. Case records of the Massachusetts General Hospital. Case 25-2013. A 71-year-old man with hematuria and a mass in the bladder.
    Olumi AF; Kaufman DS; Zietman A; Harisinghani MG; Wu CL
    N Engl J Med; 2013 Aug; 369(7):660-7. PubMed ID: 23944304
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Noburu Numao, Satoru Kawakami, Minato Yokoyama et al. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur urol 2007;52:1663-9.
    Boscolo-Berto R; Galfano A; Iafrate M
    Eur Urol; 2008 Aug; 54(2):469-70; author reply 471. PubMed ID: 18299171
    [No Abstract]   [Full Text] [Related]  

  • 15. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
    Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
    BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891). Eur Urol 2008;53:941-9.
    Ragavan N; Singh PB; Martin FL; Baird AD
    Eur Urol; 2009 Feb; 55(2):e43-4. PubMed ID: 18771846
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cystic prostate cancer: a clinical entity of ductal carcinoma].
    Zini L; Villers A; Leroy X; Ballereau C; Lemaitre L; Biserte J
    Prog Urol; 2004 Jun; 14(3):411-3. PubMed ID: 15373189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal adenocarcinoma of the prostate with oncocytic morphology.
    Punjabi LS; Ng CK; Cheng L; Tan PH
    Pathology; 2024 Apr; 56(3):415-419. PubMed ID: 37739923
    [No Abstract]   [Full Text] [Related]  

  • 19. My approach to intraductal lesions of the prostate gland.
    Pickup M; Van der Kwast TH
    J Clin Pathol; 2007 Aug; 60(8):856-65. PubMed ID: 17237185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic ductal adenocarcinoma: a mini review.
    Epstein JI
    Med Princ Pract; 2010; 19(1):82-5. PubMed ID: 19996627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.